Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Eosinophilia Among Primary Care Patients
A Cross-sectional Study to Characterize the Prevalence of COPD and Eosinophilia Among Primary Care Patients in Brazil
Sponsor: GlaxoSmithKline
A observational or N/A phase clinical study on Pulmonary Disease, Chronic Obstructive, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 16 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
16 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2022 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Nov 2021 — May 2022 [monthly]
Recruiting
-
Feb 2021 — Nov 2021 [monthly]
Recruiting
▶ Show 11 earlier versions
-
Jan 2021 — Feb 2021 [monthly]
Recruiting
-
Dec 2019 — Jan 2021 [monthly]
Recruiting
-
Jul 2019 — Dec 2019 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Apr 2019 — Jul 2019 [monthly]
Not Yet Recruiting
-
Feb 2019 — Apr 2019 [monthly]
Not Yet Recruiting
-
Sep 2018 — Feb 2019 [monthly]
Not Yet Recruiting
-
Jun 2018 — Sep 2018 [monthly]
Not Yet Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Not Yet Recruiting
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Not Yet Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Not Yet Recruiting NA
-
Feb 2017 — Jun 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- GlaxoSmithKline
For direct contact, visit the study record on ClinicalTrials.gov .